Background: French farmers and their families constitute an informative population to study multiple sclerosis (MS) prevalence and related epidemiology. We carried out an ecological study to evaluate the association of MS prevalence and ultraviolet (UV) radiation, a candidate climatologic risk factor. Methods: Mean annual and winter (December-March) UVB irradiation values were systematically compared to MS prevalence rates in corresponding regions of France. UVB data were obtained from the solar radiation database (SoDa) service and prevalence rates from previously published data on 2,667 MS cases registered with the national farmer health insurance system, Mutualité Sociale Agricole (MSA). Pearson correlation was used to examine the relationship of annual and winter UVB values with MS prevalence. Male and female prevalence were also analyzed separately. Linear regression was used to test for interaction of annual and winter UVB with sex in predicting MS prevalence.
hypothesis for the increasing MS sex ratio has been changes to sunlight exposure of vitamin D synthesizing skin.
France is considered a region of medium to high MS prevalence. 8, [12] [13] [14] The estimated rate in individuals under Mutualité Sociale Agricole (MSA) care is 65.0 per 100,000 (62.5 to 67.5). 15 The MS rates in France appear to follow a southnorth increasing gradient, although a SW-NE gradient appears to also be operative. 15, 16 Here we examine UVB radiation in relation to male and female MS prevalence in the French farming population, who are cared for under the Agricole health care system, MSA. This is an ideal population because the MSA has exclusive coverage of farmers, their families, and farm workers, as well as being ethnically homogeneous, having low migration rates, and having a relatively even population distribution throughout France. We focused specifically on the biologically active part of the UV spectrum, UVB, which contains the light wavelengths required for cutaneous photoproduction of vitamin D. 17 METHODS In this cross-sectional ecological study, we used UV satellite data estimates and reported prevalence figures for France to examine whether the MS prevalence gradient was correlated with annual or seasonal UVB measures. We similarly examined sex differences with respect to UVB levels across regions.
Study group and prevalence data. The regional prevalence figures were obtained from a previously published study 15 (prevalence day of January 1, 2003) , in which the rates were calculated from the computerized database of the MSA, and standardized for age to the general French population. 15 Rates are expressed per 100,000 individuals.
There are 22 regions of the MSA, which provides health insurance to farmers in France. It is a branch of the social security system under social protection in France. The MSA manages the social risk of rural workers, comprising farmers, salaried workers, and their families. 15 The MSA population has complete and exclusive coverage of this farmer group, 18 ). This Web site provides a range of databases, algorithms, and time series services for collecting information on solar radiation and associated climate features. 19 These databases are produced by the processing of satellite images, largely from the Meteosat series of satellites. 20,21 UVB is measured by a biometer for solar light which assesses global irradiance (290 -320 nm) with a measurement error of less than 5%. 20 The services we employed for the current study are accessed through the SoDa Web site, under the "climate normals typical values" heading. The data used are standard monthly means of daily sums for UVB radiation. Model input criteria selected for latitude and longitude were based on prefecture cities of the 22 MSA regions in France. Default model input variables provided by the service were used for ozone levels, altitude, and inclination. The "all sky" UVB model was selected over "clear sky" as the latter provides the maximum value, whereas the former provides an average value. Output data for global irradiation were used for analysis as they comprise both diffuse and direct radiation. Verification of the models used and a review of the services have been previously published. 20, 22 A map of France illustrating the variation in intensity of total irradiation was produced from data available through SoDa services. 18 The quantities illustrated are the annual irradiation (kWh/m 2 ) calculated from 2004. The irradiation data are computed from satellite observations which calculate quantity of energy that reaches the ground in Europe (DLR, University of Oldenburg, MINES ParisTech, 2005).
Data analyses.
Pearson correlation was used to examine the relationship of overall prevalence rates and annual UVB per MSA region. This was also completed for average winter UVB. Both annual and winter UVB values were then analyzed separately in males and females. We employed Pearson correlation to assess the association of latitude with MS prevalence, and with mean UVB.
Sex ratio was calculated by dividing the number of female patients with MS per 100,000 MSA affiliates by the number of male cases per 100,000 MSA affiliates for each region. Given that ratios have infinite variance and are problematic variables to model, they were not used in regression analysis. A linear model with prevalence rate predicted by UVB, sex, and UVB-sex interaction was employed to examine gender differences in MS prevalence.
Data were analyzed and graphs produced in SPSS 16.0 (Chicago 23 ) and regression modeling was done using R statistical package (Vienna 24 ).
RESULTS Characteristics of dataset. The population size, prevalence rates, sex ratio, and latitude for each of the 22 MSA regions in France are given in table 1. For each region, typical values of solar UVB are shown for annual mean (monthly values averaged over a 12-month period) and winter mean (average of December to March monthly values, table 1). MS prevalence rates increased with increasing latitude and decreasing UVB values. Latitude was strongly correlated with prevalence rates (r ϭ 0.78, p Ͻ 0.001) and with annual global UVB (r ϭ Ϫ0.96, p Ͻ 0.001) in the 22 regions of France we studied. The correlation of MS prevalence with longitude was not significant (data not shown).
Prevalence, gender, and UVB. Descriptively, it can be seen that overall prevalence rates for MS are related to the intensity of solar UV radiation in the corresponding regional districts of France (figure 1). MS prevalence was strongly associated with annual global UVB (r ϭ Ϫ0.80, p Ͻ 10 Ϫ5 ) and winter mean (r ϭ Ϫ0.87, p Ͻ 10 Ϫ6 ; table 2). There was a notable difference between the strength of the correlation of MS prevalence with UVB between men and women (table 2). Female MS prevalence was correlated with average annual UVB (r ϭ Ϫ0.76, p Ͻ 10 Ϫ4 ), as well as winter UVB average (r ϭ Ϫ0.80, p Ͻ 10 Ϫ5 ; table 2). Similarly, male MS prevalence was correlated with annual (r ϭ Ϫ0.46, p ϭ 0.032) and winter UVB (r ϭ Ϫ0.56, p ϭ 0.016; table 2). The association of male and female prevalence rates with annual UVB irradiation is illustrated (figure 2). As annual UVB decreases, the rate at which female prevalence increases is higher than the rate at which male prevalence increases (figure 2 and table 3) .
These sex differences were examined using linear regression and a significant interaction between sex and UVB was observed. For mean annual UVB, an interaction with gender was observed (␤ ϭ 15.4, t [40] ϭ 3.2, p ϭ 0.003) and the predictor variables explained a significant proportion of the variance in prevalence (R 2 ϭ 0.82, F 3,40 ϭ 66.9, p Ͻ 10 Ϫ14 ; 
DISCUSSION
The correlation of increasing latitude and increasing MS prevalence has been wellestablished. However, latitude itself is unlikely to be an independent MS risk factor, and presumably it is the correlates of latitude which explain these observations. Although sunshine exposure is a primary candidate, there are surprisingly few studies that have directly examined the UVR-MS relationship. 25 Here we examined measurements of UVB radiation data from France and how they varied in different zones of MS frequency.
Higher levels of UVB irradiation were strongly associated with lower MS prevalence rates in the French population using the MSA health system. Given their relatively homogenous genetic background, this implicates UV exposure as an environmental or genetic-environmental factor in MS susceptibility. Similar findings in Newfoundland and Labrador, Canada, showed a correlation of increasing MS incidence with decreasing erythemal UVR 25 and in Australia between prevalence and UVR. 26 The latter study examined 6 regions in Australia, finding similar correlation values to the current findings (r ϭ Ϫ0.91, p ϭ 0.01 26 ), albeit slightly higher. We also observed a trend for increasing prevalence in a westeast direction, although this cline seems to be restricted to regions above 45°N. This has been previously reported 15 and reasons may be a result of proximity to coastal regions. Indeed, looking at inland regions such as Limousin, Centre, Ile de France, and Picardie, they all have higher prevalence rates than neighboring coastal MSA regions at similar latitude (see figure 1 ). This could occur as a direct result of higher UV intensity around the ocean/sea border or result from other lifestyle factors related to living in coastal areas.
It has been proposed that the higher preponderance of MS in females results from ubiquitous population-based environmental factors, one of which is sunlight exposure. 11, 27 We found that MS The regression fit line for males and females is shown. prevalence in females was more highly correlated with UVB exposure than it was in males. Regression modeling showed that the effect of UVB on prevalence rates differed by gender. In other words, the rate at which MS prevalence increased with decreasing UVB was higher in females than in males. These data are cautiously interpreted given that ecological data are limited in their ability to postulate conclusions. Gender-specific prevalence data and corresponding UV data from other geographic locations will be informative in determining if this relationship is replicable and significant in other populations. It is unclear whether these results can extend to other countries, but it is tempting to propose that they would at least be applicable to regions with MS epidemiology similar to France. Although it is probable that this is a general trend consistent in other populations, it is not always amenable to study as we have done here. Homogenous patient groups (genetically and culturally) are needed as ethnically diverse groups within a small geographic location can have significantly different prevalence rates. 28 Relatively low frequencies of migration and consistent ascertainment methods across latitudes are also important in limiting bias. Some countries are intrinsically less discriminating, simply due to lack of latitudinal variation and UV variability throughout the country. These qualities give the data from the France MSA a unique advantage. 15 UVB data were only available at a population level, which limits the ability to account for individual variance in exposure. Lack of outdoor activity, use of sunscreen, and UV-restrictive clothing are examples of lifestyle factors which that could impact the assessment of UVB exposure with MS risk. However, it is possible that accounting for such behaviors would actually serve to strengthen the observed association. Exposure data on individual patients may be most useful in populations or locations that are exceptions to the UV gradient hypothesis. These include the reverse latitude gradient observed in Norway, 29 prevalence variability among different ethnic groups in the same region, 6, 28, 30 resistance to MS in indigenous populations, 29, 31, 32 and the high prevalence of MS in Sardinia, 33 among others. Such exceptions may result from putative protective environmental factors including fish-rich diets, 29, 34 protective/predisposing genetic factors, cultural practices, or other as yet unidentified reasons.
Other correlates of latitude may include factors such as genetic risk profile, distribution and timing of exposure to viral infections, cultural practices, socioeconomic factors, and job type, among others. Additional data on these variables were not available for the population studied and thus could not be included as covariates. However, it is unlikely that most of these would follow such a striking southnorth gradient, although the possibility that these variables intrinsically influence the strength of the UVB-MS association cannot be ruled out.
There are several possible mechanisms through which UVB radiation could be mediating the effect on MS risk. The most attractive explanation is UVBinduced synthesis of cutaneous vitamin D, which is the principal source of this metabolite. However, concentrations of vitamin D were not measured in this cohort and therefore potential mechanisms related to vitamin D can only be speculative. Interestingly, previous studies have shown gender differences in vitamin D metabolism and concentrations in patients with MS. 35, 36 Seasonal effects on MS risk have been shown previously. 27, 37, 38 The relationship between UVB levels and MS prevalence was slightly stronger in the winter months. Levels of 25(OH)D in the French population are relatively low during the winter period 39 and extension of the present study to investigate variability in population levels of 25(OH)D among the 22 MSA regions would be useful. In addition, vitamin D may be operative through a gene-environment route. Recent findings show regulation of HLA-DRB1*1501, the most significantly associated MS gene, via vitamin D-responsive element in its promoter region. 40 The current results indicate that UVB radiation influences MS prevalence rates in France. There was a significant gradient of increasing prevalence with decreasing UVB and the trend was slightly stronger in winter, as well as in females. The findings suggest UVB is likely an important environmental factor in MS susceptibility and it may influence genderspecific differences in disease risk.
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